Oral choline decreases brain purine levels in lithium-treated subjects with rapid-cycling bipolar disorder: a double-blind trial using proton and lithium magnetic resonance spectroscopy.
暂无分享,去创建一个
In Kyoon Lyoo | P. Renshaw | I. Lyoo | K. Ahn | C. Demopulos | Perry F Renshaw | Christina M Demopulos | Fuyuki Hirashima | Kyung Heup Ahn | F. Hirashima
[1] D. Janowsky,et al. Parasympathetic suppression of manic symptoms by physostigmine. , 1973, Archives of general psychiatry.
[2] N. Kato,et al. Association of bipolar disorder with the 5178 polymorphism in mitochondrial DNA. , 2000, American journal of medical genetics.
[3] N. Kato,et al. Altered brain energy metabolism in lithium-resistant bipolar disorder detected by photic stimulated 31P-MR spectroscopy , 2000, Psychological Medicine.
[4] J. Rosenbaum,et al. Measurement of human brain lithium in vivo by MR spectroscopy. , 1993, AJNR. American journal of neuroradiology.
[5] A. Stoll,et al. Basal ganglia choline levels in depression and response to fluoxetine treatment: An in vivo proton magnetic resonance spectroscopy study , 1997, Biological Psychiatry.
[6] T. Kato. DNA polymorphisms and bipolar disorder. , 2001, The American journal of psychiatry.
[7] A. Stoll,et al. Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex. , 2000, Bipolar disorders.
[8] M. Fava,et al. A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity , 1998, Psychiatry Research: Neuroimaging.
[9] A. Stoll,et al. Choline ingestion increases the resonance of choline-containing compounds in human brain: An in vivo proton magnetic resonance study , 1995, Biological Psychiatry.
[10] P F Renshaw,et al. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. , 1997, The American journal of psychiatry.
[11] R. C. Young,et al. A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.
[12] A. Stoll,et al. Variability of brain lithium levels during maintenance treatment: A magnetic resonance spectroscopy study , 1995, Biological Psychiatry.
[13] B. Cohen,et al. Lecithin in the treatment of mania: double-blind, placebo-controlled trials. , 1982, The American journal of psychiatry.
[14] D. Janowsky,et al. A cholinergic-adrenergic hypothesis of mania and depression. , 1972, Lancet.
[15] R. Kikinis,et al. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging , 1992, Journal of magnetic resonance imaging : JMRI.
[16] S. Rauch,et al. Clinical Neuroimaging in Psychiatry , 1995, Harvard review of psychiatry.
[17] D. Chuang,et al. The mitochondrial hypothesis of bipolar disorder. , 2000, Bipolar disorders.
[18] P. V. van Zijl,et al. Proton NMR spectroscopy of solvent‐saturable resonances: A new approach to study pH effects in Situ , 1998, Magnetic resonance in medicine.
[19] A. Stoll,et al. Choline in the treatment of rapid-cycling bipolar disorder: Clinical and neurochemical findings in lithium-treated patients , 1996, Biological Psychiatry.
[20] C. Hardy,et al. Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance. , 1989, Clinical chemistry.
[21] T. Inubushi,et al. Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. , 1994, Journal of affective disorders.
[22] C. Decanniere,et al. Correlation of rapid changes in the average water diffusion constant and the concentrations of lactate and ATP breakdown products during global ischemia in cat brain , 1995, Magnetic resonance in medicine.
[23] B. Cohen,et al. Lecithin in mania: a preliminary report. , 1980, The American journal of psychiatry.
[24] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[25] B. Miller. A review of chemical issues in 1H NMR spectroscopy: N‐acetyl‐l‐aspartate, creatine and choline , 1991, NMR in biomedicine.
[26] N. Kato,et al. Mitochondrial DNA polymorphisms in bipolar disorder. , 2001, Journal of affective disorders.
[27] Stefan Riehemann,et al. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients , 1998, European Archives of Psychiatry and Clinical Neuroscience.
[28] N. Kato,et al. Mitochondrial dysfunction in bipolar disorder. , 2000, Bipolar disorders.
[29] D. Jenden,et al. Choline levels in erythrocytes and plasma: A study of species variation , 1989, Biological Psychiatry.
[30] P. V. van Zijl,et al. In situ changes in purine nucleotide and n‐acetyl concentrations upon inducing global ischemia in cat brain , 1993, Magnetic Resonance in Medicine.
[31] W. Millington,et al. Choline Administration Elevates Brain Phosphorylcholine Concentrations , 1982, Journal of neurochemistry.
[32] F. McMahon,et al. Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder , 1997, Biological Psychiatry.
[33] A. Stoll,et al. Erythrocyte choline concentrations in psychiatric disorders , 1991, Biological Psychiatry.
[34] P F Renshaw,et al. Multinuclear magnetic resonance spectroscopy studies of brain purines in major depression. , 2001, The American journal of psychiatry.
[35] T. Kato,et al. Deletion of leukocyte mitochondrial DNA in bipolar disorder. , 1996, Journal of affective disorders.
[36] S. Rapoport,et al. Energy requirements for two aspects of phospholipid metabolism in mammalian brain. , 1998, The Biochemical journal.